Roadmap to De-risk Commercialization a Rare Disease Product

Roadmap to De-risk Commercialization of a Rare Disease Product

Foundations and innovation in commercial planning for a rare disease launch

With increased competition, price pressures, and customer expectations, preparing for a rare disease drug launch is more challenging than ever before. In this presentation Herspiegel Consulting with share our experience with rare disease product launches, including:
  • Identify critical commercial planning activities to accelerate forecast attainment
  • Assess key technology tools that can create greater visibility and responsiveness to market dynamics
  • Hear real-world examples of common roadblocks and mitigation strategies to avoid delaying your launch

Author

Beth Schurman

Partner, Chief Operating Officer

Beth Schurman, COO

Vincent Piccioni

Manager

Vincent Piccioni

Watch the Presentation

Complete the form to receive a link to the presentation.

Do you have a rare disease product in development?

We have experience in more than 75 launches in multiple therapeutic areas including cell & gene therapy, oncology, and rare diseases.